RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights

Author's Avatar
May 15, 2023

RenovoRx%2C+Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of cancers, today announced financial results for the first quarter ended March 31, 2023.